Abstract:Background Many studies have shown that the serum uric acid (SUA) level is one of the cardiovascular risk factors. The aim of the study is to evaluate the relationship between SUA levels and the severity of coronary artery disease (CAD) assessed by angiography and the Syntax score in patients with obstructive CAD.Methods Participants who visited our hospital for a coronary angiography, from December 2007 to September 2012, were eligible for this analysis. SUA and other blood parameters after at least 12-hour fast were determined. First, the patients were divided into tertiles according to their Syntax scores (low Syntax score group: Syntax score <= 10.0; moderate Syntax score group: 10.0 18.0). Second, to clarify the association between SUA levels and major adverse cardiovascular events (MACEs), all patients were divided into two subgroups on the basis of SUA levels. The cutoff value of SUA was defined by diagnostic criteria of hyperuricemia. Patients were separated into normal SUA group (n=251, with SUA <416 mu mol/L for men and SUA <357 mu mol/L for women) and high SUA group (n=96, with SUA >= 416 mu mol/L for men and SUA >= 357 mu mol/L for women). All participants were followed for a mean of 22.0 months (1-75 months, interquartile range: 28 months) for major adverse cardiovascular events (MACEs), including all-cause death, recurrent nonfatal myocardial infarction (re-MI) and recurrent percutaneous coronary intervention (re-PC!).Results A total of 347 patients were registered for the study. The SUA levels in the high Syntax score group were significantly higher than that of the moderate Syntax score group and the low Syntax score group ((392.3 +/- 81.6) mu mol/L vs. (329.9 +/- 71.0) mu mol/L, P<0.001; (392.3 +/- 81.6) mu mol/L vs. (311.4 +/- 64.7) mu mol/L, P <0.001). The SUA level was positively correlated not only with the Syntax score (r=0.421, P <0.001; 95% Cl: 0.333-0.512), but also with the number of diseased vessels (r=0.298, P <0.001; 95% Cl: 0.194-0.396). After multiple linear regression analysis, SUA levels were identified to be independently correlated with a high Syntax score (B=0.033, 95% Cl 0.023-0.042, P <0.001). Compared with the normal SUA subgroup, the high SUA subgroup tended to have a higher Syntax score (19.9 +/- 8.7 vs. 13.6 +/- 7.5, P <0.001) and more multi-vessel disease (70.8% vs. 46.6%, P <0.001). Follow-up data showed a higher incidence of MACE in the high SUA subgroup (20.8% vs. 6.0%, P <0.001). Binary Logistic regression analysis indicated that the elevated SUA can predict the long-term prognosis of patients with obstructive CAD (OR=2.968, 95% Cl 1.256-7.011, P=0.013). Kaplan-Meier analysis showed a significantly lower event-free survival rate in patients with high SUA levels than in the normal SUA subgroup (79.2% vs. 94.0%, Log rank=17.645, P<0.001).Conclusions SUA levels were independently associated with the severity of CAD in patients with obstructive CAD. An elevated SUA is associated with cardiovascular events and may be useful as a biomarker of the severity of CAD.

[Association of Serum Uric Acid Level with Amyotrophic Lateral Sclerosis].

Serum Uric Acid Levels Predict Mortality Risk in Male Amyotrophic Lateral Sclerosis Patients

Serum Uric Acid and Risk of Incident Chronic Kidney Disease: a National Cohort Study and Updated Meta-Analysis.

Association Between Serum Uric Acid Levels and Long-Term Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease: a Nationwide Cohort Study

The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study

Alteration of serum bile acids in amyotrophic lateral sclerosis

Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone

Cystatin C is associated with poor survival in amyotrophic lateral sclerosis patients

The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-analysis.

Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study.

Plasma Uric Acid Helps Predict Cognitive Impairment in Patients with Amyotrophic Lateral Sclerosis

Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis

[The Relation Between Plasma Homocysteine Level and Amyotrophic Lateral Sclerosis].

Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study

Associations of cerebrospinal fluid profiles with severity and mortality risk of amyotrophic lateral sclerosis

Serum Uric Acid is Independently Associated with Aortic Arch Calcification in a Cross-Sectional Study of Middle-Aged and Elderly Women

Serum Uric Acid is Inversely Related to Acute Ischemic Stroke Morbidity in Hemodialysis Patients.

Association Between Serum Uric Acid Level and the Severity of Coronary Artery Disease in Patients with Obstructive Coronary Artery Disease.

Serum uric acid as a predictor of mortality in patients with stroke: results from National Health and Nutrition Examination Survey 2007–2016

Serum Creatinine Protects Against Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study

Changes in serum uric acid, glutathione, and amyloid-β1-42 levels in Parkinson's disease patients and their association with disease progression and cognitive decline